Showing 2671-2680 of 4067 results for "".
- Lung Cancer Treatment: Evaluating Surgery, Radiation, and Novel Therapieshttps://reachmd.com/news/lung-cancer-treatment-evaluating-surgery-radiation-and-novel-therapies/2483578/As lung cancer persists as a formidable adversary in oncology, the clinical landscape for Non-Small Cell Lung Cancer (NSCLC) treatment is rapidly evolving. With the rising prominence of stereotactic body radiation therapy (SBRT) for medically inoperable early-stage disease—as endors
- CollPlant Advances Light-Activated Regenerative Filler Toward Clinical Trialshttps://reachmd.com/news/collplant-advances-light-activated-regenerative-filler-toward-clinical-trials/2483589/CollPlant Biotechnologies has announced the completion of a nonclinical program supporting the development of its photocurable dermal filler, which combines hyaluronic acid with a modified form of recombinant human collagen (rhCollagen). The company plans to advanc
- Revolutionizing Chronic Kidney Disease Classification: The Promise of NORAhttps://reachmd.com/news/revolutionizing-chronic-kidney-disease-classification-the-promise-of-nora/2483541/Chronic kidney disease (CKD) affects millions globally, yet accurately classifying it remains a formidable clinical challenge. The Nephrology-Oriented Representation leArning (NORA) approach is actively
- Phase I Clinical Insights on Obrixtamig: Targeting DLL3-Positive Cancershttps://reachmd.com/news/phase-i-clinical-insights-on-obrixtamig-targeting-dll3-positive-cancers/2483521/In the relentless pursuit to conquer aggressive forms of cancer, obrixtamig represents a beacon of hope for those battling DLL3-positive carcinomas. Small cell lung cancer (SCLC) presents unique challenges in oncologic care, with exploration extending to other DLL3‑positive neuroendocrine t
- Ocrelizumab: Leading the Charge in MS Relapse Managementhttps://reachmd.com/news/ocrelizumab-leading-the-charge-in-ms-relapse-management/2483527/In the dynamic landscape of multiple sclerosis (MS), managing relapses represents an ever-present challenge, as reflected in major society recommendations for disease-modifying therapy in relapsing forms of MS. Ocrelizumab is carving out its place as a pivotal player in this arena, promisin
- FDA's Shift in Eylea HD Approval: Navigating the Clinical Path Aheadhttps://reachmd.com/news/fdas-shift-in-eylea-hd-approval-navigating-the-clinical-path-ahead/2483507/Regulatory review timelines for Regeneron’s high-dose formulation of aflibercept, Eyl
- Dr. Anthony Brissett Named President of AAFPRS for 2025–2026 Termhttps://reachmd.com/news/dr-anthony-brissett-named-president-of-aafprs/2483515/Anthony E. Brissett, MD, FACS, a facial plastic and reconstructive surgeon based in Houston, has been named President of the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) for the 2025–2026 term. His appointment was formalized during the AAFPRS Annual Business Meeting held
- Advancing Radiology: Deep Learning & Innovative Contrast Techniqueshttps://reachmd.com/news/advancing-radiology-deep-learning-innovative-contrast-techniques/2483448/In the realm of diagnostic imaging, a transformation is underway as deep learning algorithms and innovative contrast agents such as CO2 reshape the efficiency and accuracy of radiological practices. At the forefront of this evolution, radiologists are integrating cutting-edge techno
- Transforming Obesity Management: Integrating Drug Therapies, Dietary Insights, and Brown Fat Activationhttps://reachmd.com/news/transforming-obesity-management-integrating-drug-therapies-dietary-insights-and-brown-fat-activation/2483439/The global battle against obesity is intensifying, with innovative strategies targeting its fundamental mechanisms now reshaping the landscape of metabolic health treatments. Cutting-edge drug therapies, dietary insights, and advancements in brown fat activation are at the forefront
- Redefining Neurosurgery: The Role of Robotics and Machine Learninghttps://reachmd.com/news/redefining-neurosurgery-the-role-of-robotics-and-machine-learning/2483399/Neurosurgery is at a pivotal juncture, where cutting-edge technological advances are forging paths to unprecedented levels of precision and improved patient outcomes. In this landscape, the integration of robotics and machine learning (ML) is more than just innovation—it’s a revolut